40,492 Shares in Evolent Health, Inc. (NYSE:EVH) Acquired by Natixis

Natixis bought a new position in shares of Evolent Health, Inc. (NYSE:EVH) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 40,492 shares of the technology company’s stock, valued at approximately $1,328,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. NBC Securities Inc. grew its position in Evolent Health by 16.6% during the 1st quarter. NBC Securities Inc. now owns 2,461 shares of the technology company’s stock worth $81,000 after purchasing an additional 350 shares during the last quarter. HMS Capital Management LLC raised its position in shares of Evolent Health by 7.8% in the first quarter. HMS Capital Management LLC now owns 7,419 shares of the technology company’s stock valued at $243,000 after buying an additional 538 shares during the last quarter. American International Group Inc. raised its position in shares of Evolent Health by 1.2% in the first quarter. American International Group Inc. now owns 55,402 shares of the technology company’s stock valued at $1,817,000 after buying an additional 640 shares during the last quarter. Janney Capital Management LLC raised its position in shares of Evolent Health by 7.6% in the first quarter. Janney Capital Management LLC now owns 9,543 shares of the technology company’s stock valued at $313,000 after buying an additional 671 shares during the last quarter. Finally, Genesee Capital Advisors LLC grew its holdings in Evolent Health by 2.2% in the fourth quarter. Genesee Capital Advisors LLC now owns 38,390 shares of the technology company’s stock valued at $1,268,000 after purchasing an additional 825 shares during the period.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. JMP Securities decreased their target price on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating for the company in a research note on Friday, May 10th. Citigroup began coverage on shares of Evolent Health in a report on Monday, April 22nd. They issued a “buy” rating and a $40.00 price objective on the stock. Finally, Canaccord Genuity Group dropped their price objective on shares of Evolent Health from $44.00 to $41.00 and set a “buy” rating on the stock in a report on Friday, May 10th. One analyst has rated the stock with a sell rating, one has given a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $42.00.

Evolent Health Trading Up 4.1 %

EVH stock traded up $0.87 during trading on Thursday, hitting $22.14. The company had a trading volume of 3,740,652 shares, compared to its average volume of 1,361,470. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.57. The firm has a 50-day moving average price of $21.38 and a 200-day moving average price of $27.40. Evolent Health, Inc. has a 12 month low of $17.98 and a 12 month high of $35.00. The stock has a market cap of $2.57 billion, a price-to-earnings ratio of -17.71 and a beta of 1.54.

Evolent Health (NYSE:EVH) last announced its earnings results on Thursday, May 9th. The technology company reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.04. The firm had revenue of $639.65 million during the quarter, compared to analyst estimates of $601.60 million. Evolent Health had a negative net margin of 5.07% and a positive return on equity of 6.90%. As a group, analysts predict that Evolent Health, Inc. will post 0.9 earnings per share for the current year.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.